About Acceleron Pharma
Acceleron Pharma is a company based in Cambridge (United States) founded in 2004 was acquired by Merck in September 2021.. Acceleron Pharma has raised $137.67 million across 9 funding rounds from investors including Merck, Bessemer Venture Partners and Alkermes. Acceleron Pharma offers products and services including Vaccines and Medicines.
- Headquarter Cambridge, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Merck & Co., Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acceleron Pharma
Acceleron Pharma offers a comprehensive portfolio of products and services, including Vaccines and Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops vaccines for infectious diseases and prevention.
Provides treatments for oncology and other disorders.
Unlock access to complete
Unlock access to complete
Leadership Team
442 people
Software Development Team
251 people
Product Management Team
73 people
Sales and Marketing
73 people
Senior Team
64 people
Data Analysis and Operations Team
63 people
Operations Team
54 people
Finance and Accounting
30 people
Unlock access to complete
Funding Insights of Acceleron Pharma
Acceleron Pharma has successfully raised a total of $137.67M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $30 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $30.0M
-
First Round
First Round
(13 Feb 2004)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Post-IPO - Acceleron Pharma | Valuation |
investors |
|
| Sep, 2013 | Amount | Post-IPO - Acceleron Pharma | Valuation |
investors |
|
| Jan, 2012 | Amount | Series D - Acceleron Pharma | Valuation | Celgene , Alkermes |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Acceleron Pharma
Acceleron Pharma has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, Bessemer Venture Partners and Alkermes. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm making investment in early stage startups in the US
|
Founded Year | Domain | Location | |
|
Seed and early-stage venture capital is provided to US companies.
|
Founded Year | Domain | Location | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Acceleron Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Acceleron Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acceleron Pharma Comparisons
Competitors of Acceleron Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Acceleron Pharma
Frequently Asked Questions about Acceleron Pharma
When was Acceleron Pharma founded?
Acceleron Pharma was founded in 2004.
Where is Acceleron Pharma located?
Acceleron Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Acceleron Pharma a funded company?
Acceleron Pharma is a funded company, having raised a total of $137.67M across 9 funding rounds to date. The company's 1st funding round was a Series D of $30.47M, raised on Feb 13, 2004.
What does Acceleron Pharma do?
Acceleron Pharma is a developer of protein therapeutics to treat cancer and rare blood disorders. The company is developing luspatercept and sotatercept therapeutic candidates to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes. The sotatercept therapeutic candidate is also used to increase bone mineral density, and to treat the final stage of chronic kidney disease and end-stage renal disease. It is also developing a dalantercept therapeutic candidate to treat renal cell carcinoma, hepatocellular carcinoma, and ACE-083 that is in Phase 1 clinical trial used to promote muscle growth and function in specific treated muscle groups.
What products or services does Acceleron Pharma offer?
Acceleron Pharma offers Vaccines and Medicines.
Who are Acceleron Pharma's investors?
Acceleron Pharma has 12 investors. Key investors include Merck, Bessemer Venture Partners, Alkermes, Flagship Pioneering, and Orbimed.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.